Kigelia-NT Tablet
Marketer
Advance Revive
Salt Composition
Pregabalin (75mg) + Nortriptyline (10mg)
Overview Kigelia-NT Tablet
Neuropathic pain is effectively managed by Kigelia-NT Tablets, a combined medication. These tablets interrupt pain signal transmission to the brain, thereby reducing pain perception. Administered orally, Kigelia-NT Tablets can be taken with or without food, ideally before sleep, consistently at the same time daily for optimal blood levels. Follow your physician's prescribed dosage and duration precisely, as this medication is habit-forming. If a dose is missed, take it immediately upon recollection. Complete the entire course, even with symptom improvement. Sudden discontinuation is strongly discouraged without prior consultation. Common side effects include constipation, urinary difficulty, weight gain, fatigue, and dry mouth. Dizziness and drowsiness may also occur, necessitating caution when driving or engaging in activities demanding concentration. Weight gain may result; mitigate this through regular exercise and a balanced diet. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor. Prior to commencing treatment, disclose any kidney or liver conditions, and provide a complete list of all other medications being taken, as interactions may affect Kigelia-NT's efficacy or mechanism. Inform your physician of pregnancy, pregnancy plans, or breastfeeding.
Uses of Kigelia-NT Tablet
Managing neuropathic pain
Major Benefits of Kigelia-NT Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Kigelia-NT Tablet whole; do not alter its form by chewing, crushing, or breaking it. While consumption with or without food is acceptable, consistent timing is recommended for optimal results.
Common Side effects of Kigelia-NT Tablet:
- Dryness in mouth
- Increased heart rate
- Sleepiness
- Dizziness
- Tiredness
- Weight gain
- Blurred vision
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Uncoordinated body movements
- Increased appetite
- Increased libido
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Vomiting
- Nausea
- Erectile dysfunction
- Joint pain
- Constipation
- Difficulty in urination
How to use Kigelia-NT Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or divide it. Kigelia-NT Tablets can be administered with or without food, however, consistent timing is recommended.
How Kigelia-NT Tablet works:
Kigelia-NT Tablets combine pregabalin and nortriptyline to alleviate neuropathic pain. Pregabalin, an alpha-2-delta ligand, reduces pain by regulating calcium channel function in nerve cells. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline, neurotransmitters that inhibit pain signal transmission in the brain. This dual-action mechanism provides effective relief from nerve-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Kigelia-NT tablets and alcohol may lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Kigelia-NT Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Kigelia-NT tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Kigelia-NT Tablet side effects, due to potential drowsiness induced by the medication.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Kigelia-NT Tablets; dosage modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Kigelia-NT Tablets appear to pose minimal risk for individuals with hepatic impairment. Available evidence indicates that dosage modification may not be necessary for this patient population. Physician consultation is recommended.
What if you forget to take Kigelia-NT Tablet :
Should you forget a Kigelia-NT Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Kigelia-NT Tablet
| Label | Value |
|---|---|
| Addictive | None. |
| Type of Medication | Nervous System |
FAQs on Kigelia-NT Tablet
Pregabalin and Nortriptyline, combined as Kigelia-NT Tablets, offer relief from neuropathic pain. The medication works by modulating activity in the brain, thereby soothing damaged or hyperactive nerves and reducing pain perception.
Discontinuing Kigelia-NT Tablet prematurely, even with pain relief, is inadvisable. Follow your physician's prescribed regimen. Abrupt cessation may result in withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Kigelia-NT Tablets may stimulate appetite, potentially leading to increased food consumption and weight gain. Weight maintenance is simpler than weight loss. A balanced diet with controlled portion sizes is recommended. High-calorie foods like sugary drinks, fried items, processed snacks, and desserts should be limited. Between meals, opt for fruits, vegetables, and low-calorie alternatives instead of unhealthy snacks. Regular physical activity helps prevent weight gain. Consistent healthy eating and exercise may mitigate weight increase associated with the medication.
Kigelia-NT Tablets can cause drowsiness or unexpected sleep onset during routine tasks. This sleepiness may occur without prior warning signs. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities initially, until the medication's effects are understood. Report any such incidents to your physician.
Kigelia-NT Tablet may impact the sexual experiences of men and women. Reported side effects include reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia (inability to reach orgasm). Decreased sexual satisfaction and discomfort during intercourse may also occur. Consult your physician if you encounter these issues; however, do not discontinue Kigelia-NT Tablet without medical advice.
Kigelia-NT Tablet rarely produces severe adverse reactions. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or slowed reflexes, unusual mood or behavioral shifts (including agitation, anxiety, or elation), depressive symptoms, hallucinations, illogical thought processes, visual disturbances (blurred or double vision, nystagmus), visual impairment, or indicators of recurrent infections like fever, intense chills, pharyngitis, or oral ulcers. While infrequent, these reactions require prompt medical intervention.
Visible improvement from Kigelia-NT Tablets might begin after a fortnight of use. Complete therapeutic effects, however, typically manifest within two to three months. In certain individuals, a longer duration may be necessary.
Should you miss a scheduled dose of Kigelia-NT Tablet, and your next dose is nearly due, omit the missed dose and continue with your regular schedule. If your next dose is not imminent, take the missed dose immediately upon recollection, then resume your usual medication regimen. Avoid doubling up on doses to compensate for a missed one; this could heighten the risk of adverse reactions from an overdose. For any uncertainty regarding missed doses, seek guidance from your physician.
If this occurs, promptly contact your physician or proceed to the closest emergency room. Seek medical assistance regardless of the presence or absence of symptoms. Immediate medical intervention may be necessary. Overdose signs can manifest as lethargy, debility, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Increasing the prescribed dosage won't necessarily enhance effectiveness; instead, it could heighten the risk of severe adverse reactions and harmful effects. If your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Kigelia-NT Tablets can affect cognitive function and response times. Exercise caution when operating machinery or engaging in activities demanding alertness. Alcohol consumption should be avoided while using Kigelia-NT Tablets, as it may potentiate alcoholic effects, posing a safety risk. Grapefruit and grapefruit juice may interact negatively with this medication, leading to adverse reactions. Minimize sun exposure and the use of tanning beds. Kigelia-NT Tablets increase susceptibility to sunburn; therefore, protective clothing and sunscreen are recommended during daytime outdoor activities.
Regular monitoring by your physician may be necessary following initiation of Kigelia-NT Tablet therapy. Consult your doctor immediately if your symptoms persist despite adhering to the prescribed Kigelia-NT Tablet dosage, or if you develop adverse effects impacting your daily life.
Retain the medication within its original packaging until needed. Maintain storage in a cool, dry environment. Securely store the medication where it is inaccessible to children. Proper disposal of any remaining medicine is essential to prevent accidental ingestion by children, pets, or others.
Pregabalin and Nortriptyline, combined as Kigelia-NT Tablets, provide relief from neuropathic pain. This medication works by modulating brain activity to soothe damaged or hyperactive nerves, thus reducing pain perception.
Discontinuing Kigelia-NT Tablet prematurely, even with pain relief, is inadvisable. Follow your physician's instructions for continued use. Abrupt cessation may lead to withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is recommended before complete discontinuation.
Kigelia-NT Tablets may stimulate appetite, potentially leading to increased food consumption and weight gain. Weight management is simpler than weight loss. Maintain a nutritious, balanced diet without enlarging portion sizes. Restrict high-calorie foods like sugary drinks, fried foods, processed snacks, pastries, and confectionery. Between meals, choose fruits, vegetables, and low-calorie options instead of unhealthy snacks. Regular physical activity helps prevent weight gain. Consistent healthy eating and exercise may prevent weight increase.
Kigelia-NT Tablets can cause drowsiness and sudden sleep onset during routine tasks. This may occur without prior warning signs. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities initially, until the drug's effects are understood. Report any such incidents to your physician.
Kigelia-NT Tablet may impact sexual function in both males and females. Reported side effects include reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia. Decreased sexual satisfaction and discomfort during intercourse may also occur. Consult your physician if these issues arise, but do not discontinue Kigelia-NT Tablet without medical advice.
Kigelia-NT Tablet rarely produces severe adverse reactions. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or slowed reflexes, unusual shifts in mood or behavior (including agitation, anxiety, or elation), depressive symptoms, hallucinations, illogical thought processes, visual disturbances (blurred or double vision), involuntary eye movements, vision impairment, or indications of recurrent infections like fever, intense chills, pharyngitis, or oral ulcers. While infrequent, these reactions warrant prompt medical intervention.
Visible improvement from Kigelia-NT Tablet might begin after a fortnight of use. Complete effectiveness, however, typically requires two to three months. For some individuals, a longer treatment period may be necessary.
Should you miss a scheduled dose of Kigelia-NT Tablet, and your next dose is imminent, omit the missed dose and proceed with your regular schedule. If ample time remains before the next dose, take the missed dose immediately, then resume your normal medication routine. Avoid doubling your dose to compensate for a missed one, as this could heighten the chance of adverse reactions from an overdose. For any uncertainty regarding missed doses, seek guidance from your physician.
If this occurs, promptly contact your physician or proceed to the closest emergency room. This is advisable regardless of whether any adverse effects are evident. Immediate medical care might be necessary. Overdose symptoms can manifest as lethargy, fatigue, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Increasing the prescribed dosage won't necessarily improve results; in fact, it could heighten the risk of severe adverse reactions and poisoning. Should your symptoms worsen despite adhering to the recommended dosage, seek a physician's assessment.
Kigelia-NT Tablet may reduce alertness and impair cognitive function. Exercise caution when operating machinery or engaging in activities demanding concentration. Alcohol consumption should be avoided during Kigelia-NT Tablet use due to the potential for intensified effects, posing a safety risk. Grapefruit and its juice may interact negatively with this medication, leading to adverse reactions. Limit sun exposure and avoid tanning beds; Kigelia-NT Tablet increases susceptibility to sunburn. Protective clothing and sunscreen are recommended during daylight hours.
Regular check-ups with your physician are recommended following commencement of Kigelia-NT Tablet therapy. Consult your doctor immediately if your symptoms persist despite adhering to the prescribed Kigelia-NT Tablet dosage, or if any adverse effects significantly disrupt your daily life.
Retain the medication within its original packaging until ready for administration. Maintain storage in a cool, dry environment. Keep the medication securely out of children's view and reach. Proper disposal of any remaining medicine is crucial to prevent accidental ingestion by children, pets, or others.
Pregabalin and Nortriptyline, combined as Kigelia-NT Tablets, provide relief from neuropathic pain. This medication works by modulating brain activity to soothe damaged or hyperactive nerves, thus reducing pain perception.
Discontinuing Kigelia-NT Tablet prematurely, even with pain relief, is inadvisable. Follow your physician's prescribed regimen. Abrupt cessation may trigger withdrawal effects including restlessness, insomnia, queasiness, discomfort, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Kigelia-NT Tablets may stimulate appetite, potentially leading to increased food consumption and weight gain. Weight management is simpler than weight loss. Maintain a balanced diet without enlarging portions. Restrict high-calorie foods like sugary drinks, fried foods, processed snacks, and desserts. Between meals, choose fruits, vegetables, and low-calorie options instead of junk food. Regular physical activity helps prevent weight gain. Combining a healthy diet with exercise may mitigate weight increase.
Kigelia-NT Tablets can induce drowsiness or cause sudden sleep onset during routine tasks. This sleepiness may occur without prior warning signs. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities initially, until the medication's effects are understood. Report any such incidents to your physician.
Kigelia-NT Tablet may impact the sexual experiences of male and female users. Reported side effects include reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia (inability to achieve orgasm). Decreased sexual satisfaction and discomfort during intercourse may also occur. Consult your physician if you encounter such issues, but do not discontinue Kigelia-NT Tablet without medical advice.
Kigelia-NT Tablet rarely causes severe adverse reactions. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or delayed responses, unusual mood or behavioral shifts (including agitation, anxiety, or euphoria), depressive symptoms, hallucinations, illogical thought processes, visual disturbances (blurred or double vision), involuntary eye movements (nystagmus), vision impairment, or indications of recurrent infections like fever, intense chills, pharyngitis, or oral ulcers. While infrequent, these reactions warrant prompt medical care.
Visible improvements from Kigelia-NT Tablet might appear within a fortnight of starting treatment. Complete effectiveness, however, typically develops over two to three months. For some individuals, a longer timeframe may be necessary.
Should you miss a scheduled dose of Kigelia-NT Tablet, and your next dose is nearly due, omit the missed dose and continue with your regular schedule. If your next dose is not imminent, take the missed dose immediately upon recollection, then resume your usual medication regimen. Avoid doubling up on doses to compensate for a missed one, as this could heighten the chance of adverse reactions from an overdose. For any uncertainty regarding missed doses, seek guidance from your physician.
If this occurs, promptly contact your physician or proceed to the closest emergency room. Seek medical assistance regardless of the presence or absence of adverse effects. Immediate medical care may be necessary. Overdose symptoms can manifest as lethargy, debility, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Increasing your medication dosage beyond the prescribed amount won't necessarily improve its effectiveness; instead, it could heighten the risk of adverse reactions and toxicity. If your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Kigelia-NT Tablets can affect cognitive function and reaction time. Exercise caution when operating machinery or engaging in activities demanding alertness. Alcohol consumption should be avoided while using Kigelia-NT Tablets due to the potential for intensified effects, posing a safety risk. Grapefruit and grapefruit juice may interact adversely with this medication, leading to undesirable consequences. Minimize sun exposure and the use of tanning beds. Kigelia-NT Tablets increase susceptibility to sunburn; therefore, protective clothing and sunscreen are recommended during daylight hours.
Routine check-ups with your physician are recommended following commencement of Kigelia-NT Tablet therapy. Seek immediate medical attention if your symptoms persist despite adhering to the prescribed Kigelia-NT Tablet dosage, or if adverse effects interfere with your daily life.
Retain the medication within its original packaging until ready for administration. Maintain storage in a cool, dry environment. Keep the medication out of children's view and reach. Proper disposal of any leftover medication is essential to prevent accidental ingestion by children, pets, or others.
3,018 People bought this recently
Kigelia-NT Tablet
126
MRP 154
18% off